Temperature-Regulated Insulin Case Patent for Sale

This listing presents a unique opportunity to acquire a US patent granted in 2021 for a bifurcated temperature regulation system, known as the medicament temperature regulator. Developed initially for the medical industry to maintain insulin temperature for diabetes patients, this modular and scalable intellectual property (IP) has broad applications across various sectors, including consumer products, industrial transport, food & drug, and pharmaceutical production. The sale includes a fully functioning prototype of the system, which management claims is the most technologically advanced insulin case on the market. Additional concepts for future product development, operating under the original patent, are also part of the offering. The IP is suitable for all climates and can regulate the temperature of insulin pens, syringes, vials, vaccines, and other temperature-sensitive medicaments. Opportunities abound for buyers to capitalize on the patent by bringing the final product to market, serving the vast global diabetes population, or by expanding its use into non-medical fields. Strategic development of accessories like battery replacements and chargers could also create additional revenue streams. The company is owned by a single shareholder seeking to sell or license the patent, recognizing the need for significant capital expenditure to commercialize the product.